Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut
25/10/2024 17:13
Oct 25 (Reuters) - Septerna's SEPN.O shares rose about 31% in their market debut on Friday, giving the Goldman Sachs-backed biotech firm a valuation of $970 million. (Reporting by Pritam Biswas in Bengaluru; Editing by Vijay Kishore) ((Pritam.Biswas@thomsonreuters.com;))
Recent news on Septerna
See all newsBrief: Septerna Announces Inducement Grant Under Nasdaq Listing Rule
U.S. RESEARCH ROUNDUP-Cogent Communications, Dollar Tree, Home Depot
Septerna, Inc. reports results for the quarter ended June 30 - Earnings Summary
Septerna Q2 revenue beats analyst estimates, driven by Novo Nordisk partnership
Septerna Q1 revenue rises sharply helped by Novo Nordisk collaboration